[go: up one dir, main page]

TW201201857A - Agent suppressing decrease in preservative ability in amino-acid containing composition - Google Patents

Agent suppressing decrease in preservative ability in amino-acid containing composition Download PDF

Info

Publication number
TW201201857A
TW201201857A TW100119456A TW100119456A TW201201857A TW 201201857 A TW201201857 A TW 201201857A TW 100119456 A TW100119456 A TW 100119456A TW 100119456 A TW100119456 A TW 100119456A TW 201201857 A TW201201857 A TW 201201857A
Authority
TW
Taiwan
Prior art keywords
acid
amino acid
containing composition
amino
mass
Prior art date
Application number
TW100119456A
Other languages
Chinese (zh)
Inventor
Masaki Okawa
Nobuyoshi Koga
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of TW201201857A publication Critical patent/TW201201857A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is an agent that suppresses a decrease in preservative ability in an amino-acid containing composition that has a sufficient preservative ability even if as low a concentration of preservative as possible is used in combination therewith. The agent that suppresses a decrease in preservative ability is of an amino-acid containing composition that contains D-amino acids. The aforementioned D-amino acids may be D-glutamic acid and/or D-lysine hydrochloride. The amount contained of the agent that suppresses a decrease in preservative ability in the amino-acid containing composition is 0.000015 mass% to 10 mas%, and may be used in combination with 0.01 mass% to 1.0 mass% of preservative. Provided is a cosmetic material that contains the aforementioned agent that suppresses a decrease in preservative ability in an amino-acid containing composition.

Description

201201857 六、發明說明: 【發明所屬之技術領域】 本發明係關於含D-胺基酸之含胺基酸組合物中之防腐力 降低抑制劑,具體言之,係關於含D_谷胺酸及/或d賴胺 酸鹽酸鹽之含胺基酸組合物中之防腐力降低抑制劑。 【先前技術】 化妝水、乳液、乳霜等化妝品通常將數十次之使用量填 充於1個容器内,使用時難以避免來自手指或空氣等之微 生物之混入。為防止化妝品因該微生物之變質,而於化妝 品中使用防腐劑。代表性化妝品用防腐劑包含異丙基甲基 苯酚、對羥基苯曱酸酯、2·苯氧乙醇、檜木醇等苯酚類、 苯甲酸及其鹽、水揚酸及其鹽、脫氫乙酸及其鹽、山梨酸 及其鹽等酸類、氯化苯烷銨、氯化芊銨、烷基三曱基氣化 銨等4級銨類、烷基胺基乙基甘胺酸鹽酸鹽、氯化硬脂醯 經基乙基甜菜驗鈉等兩性界面活性劑等。 但該等防腐劑有產生皮膚刺激者或如苯甲酸、水楊酸等 係會於低溫析出因此製劑之穩定性低者。再者,有如2_笨 氧乙醇般有揮發性因而揮發,於使用中化妝品之防腐力經 時降低者。 [利文獻1]本特開2006-249049號 【發明内容】 [明所欲解決之問題] 作為有保濕效果之化妝品成份或食品之營養成份’而調 配胺基酸或其鹽。但,先前調配之前述胺基酸(一般為^ I56307.doc 201201857 體)或其鹽變成微生物之營養源,有使調配物之防腐力下 降之問題。 因此’為了即使以儘可能低之濃度併用含胺基酸組合物 中調配之前述防腐劑仍具有充分防腐力,而需要開發出一 種含胺基酸組合物中之防腐力降低抑制劑。 [決問題之技術手段] 本發明提供一種含D-胺基酸之含胺基酸組合物中之防腐 力降低抑制劑。 本發明之含胺基酸組合物t之防腐力降低抑制劑中,前 述D-胺基酸有時為D-谷胺酸及/或D-賴胺酸鹽酸鹽。 本發明之含胺基酸組合物中之防腐力降低抑制劑之調配 量為0.000015質量0/〇至1〇質量% ’有時與〇 〇1質量%至1 〇質 量%之防腐劑併用。 本發明提供一種含有前述含胺基酸組合物中之防腐力降 低抑制劑之化妝品。 本說明書中,所謂含胺基酸組合物中之防腐力降低抑制 劑,意指單獨時雖無作為防腐劑之活性,但與其他防腐劑 併用時’可減低該防腐劑之調配量之組合物❶具體言之, 與先刖所調配之含胺基酸(L體)組合物相比,可提供—種 防腐劑量少即足夠之含胺基酸組合物。 本發明之含胺基酸組合物中之防腐力降低抑制劑不僅可 用於化妝品或皮膚外用劑,亦可使用於醫藥品、食品、飲 料以及有因微生物之混入而腐敗之虞之任一物品中之情 形0 156307.doc ⑧ 4· 201201857 本發明之含胺基酸組合物中之防腐力降低抑制劑所使用 之D-胺基酸包含由甘胺酸、丙胺酸、半胱胺酸、天冬胺 酸、谷胺酸、苯丙胺酸、組胺酸、異亮胺酸、賴胺酸、亮 胺酸、蛋胺酸、天門東素、脯胺酸、谷胺醯胺、精胺酸、 絲胺酸、棘胺酸、纈胺駿、色胺酸、酪胺酸所組成之2〇種 胺基酸中除甘胺酸外之19種胺基酸之立體異構物D_胺基 酸,與不限於該等之任一天然或非天然胺基酸。本發明之 申請人至今發現如曰本特願2009-2 11255(紫外線損害減輕 組合物)、日本特願2009-220983(紫外線損害減輕組合 物)、曰本特願2009-223327(紫外線損害減輕組合物)、曰 本特願2009-224742(抗氧化組合物)、日本特願2〇〇9_ 224743(促進膠原產生之組合物)、日本特願2〇〇9· 225870(促進膠原產生之組合物)、日本特願2〇〇9_ 225871(促進層粘連蛋白332產生之組合物)、日本特願 2009-225872(促進層粘連蛋白332產生之組合物)、日本特 願2009-226075(減輕皮膚粗糙之口服組合物)、日本特願 2009-226076(減輕皺紋形成之口服組合物)、日本特願 2009-228267(紫外線損害減輕之口服組合物)、 PCT/JP2〇10/53569(美白劑及美白皮膚之美容方法)、 PCT/JP2010/55841(紫外線損害減輕之口服組合物)、 PCT/JP2010/55842(抗氧化組合物)及 pcT/JP2010/55648(紫 外線損害減輕組合物)之各種申請說明書所說明,D_胺基 酸具有各種有用特性,基於該等發現而提供新穎之用途發 明。該等申請說明書之内容藉由引用其全體併入本說明書 156307.doc 201201857 中供參考。 有時與本發明之含胺基酸組合物中之防腐力降低抑制劑 併用之防腐劑,包含異丙基甲基苯酚、對羥基笨甲酸酯、 2-苯氧乙醇、檜木醇等㈣、苯甲酸及其鹽、水揚酸及其 鹽、脫氫乙酸及其鹽、山梨酸及其鹽等酸類、氯化苯炫 銨、氯化苄銨、烷基三甲基氣化銨等4級銨類、烷基胺基 乙基甘胺酸鹽酸鹽、氣化硬脂醯經基乙基甜菜驗鈉等兩性 界面活性劑等》但不限於該等。 【實施方式】 以下所說明之本發明之實施例僅以例示為目的,不限定 本發明之技術範圍。本發明之技術範圍僅由專利申請範圍 之記載所限定。 實施例1201201857 VI. Description of the Invention: [Technical Field] The present invention relates to a corrosion-inhibiting inhibitor in an amino acid-containing composition containing a D-amino acid, in particular, a D-glutamic acid-containing And/or an anti-corrosion reducing inhibitor in the amino acid-containing composition of d-lysamine hydrochloride. [Prior Art] Cosmetics such as lotions, lotions, and creams are usually filled in one container for dozens of times, and it is difficult to avoid the incorporation of microorganisms such as fingers or air during use. In order to prevent cosmetics from deteriorating due to the microorganism, preservatives are used in cosmetics. Representative cosmetic preservatives include isopropyl phenol, p-hydroxybenzoic acid ester, phenoxyethanol, phenolic acid such as benzyl alcohol, benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and An acid such as a salt, a sorbic acid or a salt thereof, a quaternary ammonium chloride, an ammonium cerium chloride, an alkyl tridecyl ammonium halide, a 4- to ammonium, an alkylaminoethyl glycine hydrochloride, or a chlorine The stearyl hydrazine is subjected to an amphoteric surfactant such as sodium by a base beet test. However, such preservatives may cause skin irritation or such as benzoic acid, salicylic acid, etc., which may precipitate at a low temperature and thus have low stability of the preparation. Further, it is volatile as in the case of 2_oxyethanol, and volatilizes, and the antiseptic property of the cosmetic is lowered in use. [Problem 1] Unexamined Patent Publication No. 2006-249049 [Draft of the Invention] [A problem to be solved] An amino acid or a salt thereof is formulated as a cosmetic component having a moisturizing effect or a nutrient component of a food. However, the previously formulated amino acid (generally, I56307.doc 201201857) or a salt thereof becomes a nutrient source of microorganisms, and there is a problem that the antiseptic property of the formulation is lowered. Therefore, in order to have sufficient corrosion resistance even if the aforementioned preservative formulated in the amino acid-containing composition is used in the lowest possible concentration, it is required to develop an anti-corrosion reducing inhibitor in the amino acid-containing composition. [Technical means for solving the problem] The present invention provides a corrosion-inhibiting inhibitor in an amino acid-containing composition containing a D-amino acid. In the anti-corrosion reducing inhibitor of the amino acid-containing composition t of the present invention, the aforementioned D-amino acid is sometimes D-glutamic acid and/or D-lysine hydrochloride. The amount of the anti-corrosion reducing inhibitor in the amino acid-containing composition of the present invention is 0.000015 mass% / Torr to 1 〇 mass%, which is sometimes used in combination with 〇1% by mass to 1% by mass of the preservative. The present invention provides a cosmetic comprising the anti-corrosion reducing inhibitor in the aforementioned amino acid-containing composition. In the present specification, the anti-corrosion reducing inhibitor in the amino acid-containing composition means a composition which can reduce the amount of the preservative when used together with other preservatives, although it has no activity as a preservative alone. Specifically, an amino acid-containing composition having a small amount of preservative is provided as compared with the amino acid-containing (L body) composition formulated by the sputum. The antiseptic reducing agent in the amino acid-containing composition of the present invention can be used not only in cosmetics or skin external preparations, but also in medicines, foods, beverages, and any kind of articles which are spoiled by the incorporation of microorganisms. Case 0 156307.doc 8 4· 201201857 The D-amino acid used in the anti-corrosion reducing inhibitor of the amino acid-containing composition of the present invention comprises glycine, alanine, cysteine, aspartame Aminic acid, glutamic acid, phenylalanine, histidine, isoleucine, lysine, leucine, methionine, aspartame, valine, glutamine, arginine, silk a stereoisomer D-amino acid of 19 amino acids other than glycine in the amino acid consisting of acid, echinoic acid, guanamine, tryptophan and tyrosine, and It is not limited to any of these natural or non-natural amino acids. The applicant of the present invention has found, for example, that the Japanese Patent Application No. 2009-2 11255 (Ultraviolet Damage Reduction Composition), Japanese Patent Application No. 2009-220983 (Ultraviolet Damage Reduction Composition), and the Japanese Patent Application No. 2009-223327 (UV Damage Reduction Combination) ) 特 2009 2009-224742 (antioxidant composition), Japan's special offer 2〇〇9_ 224743 (composition for promoting collagen production), Japan's special offer 2〇〇9· 225870 (composition for promoting collagen production) ), Japanese special offer 2〇〇9_ 225871 (composition for promoting laminin 332), Japanese Patent No. 2009-225872 (combination for promoting laminin 332), Japanese Patent No. 2009-226075 (Reducing skin roughness) Oral composition), Japanese Patent Application No. 2009-226076 (oral composition for reducing wrinkle formation), Japanese Patent Application No. 2009-228267 (oral composition for reducing ultraviolet damage), PCT/JP2〇10/53569 (whitening agent and whitening) Various cosmetic application methods of PCT/JP2010/55841 (oral composition for reducing ultraviolet damage), PCT/JP2010/55842 (antioxidant composition), and pcT/JP2010/55648 (ultraviolet damage reduction composition) As indicated, D-amino acids have a variety of useful properties and provide novel uses based on such findings. The contents of these application notes are hereby incorporated by reference in its entirety by reference in its entirety by reference in its entirety in its entirety in its entirety in a preservative sometimes used in combination with a preservative lowering inhibitor in the amino acid-containing composition of the present invention, comprising isopropylmethylphenol, p-hydroxyformate, 2-phenoxyethanol, eucalypol, etc. (4), Benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and its salts, acid such as sorbic acid and its salts, benzylammonium chloride, benzylammonium chloride, alkyltrimethylammonium vaporate, etc. Ammonium, alkylaminoethylglycine hydrochloride, vaporized stearin, amphoteric surfactant such as sodium formate test, etc., but not limited thereto. [Embodiment] The embodiments of the present invention described below are for illustrative purposes only and do not limit the technical scope of the present invention. The technical scope of the present invention is limited only by the description of the scope of the patent application. Example 1

防腐效果試驗係如下實施 或L_體0.5%(質量比, 。谷胺酸或賴胺酸鹽酸鹽之D· 以下相同)、5%之硝化甘油 (Dynamite glycerol)、〇.5%之2·苯氧乙醇溶解於剩餘之去 離子水中,調製樣本。未添加胺基酸之樣本作為對照使 用。對30 g樣本接種106 cfu/g之大腸桿菌或金黃葡萄球 菌,於25°C下保存。樣本調製時(0天)與保存第3、5、 1〇、14天,以無菌棉棒採取樣本之一部份,塗抹於瓊脂培 養基上,以30°C培養2天後,測量所形成之菌落數。菌落 數超過約100個之情形時,根據菌落數記錄為+++、及 +。菌落全然未形成時記錄為—。 防腐效果試驗之結果如以下表丨及表2所示。 156307.doc -6 · 201201857 [表1] 大腸桿菌 對照 谷β (0. Τ 5%) 賴胺酸鹽酸鹽 (0.5%) 第0天 +-H- ++Η- D +Ή-— L +-H- D HH- 弟3天 第5天 24 6 ··~~~-~~-— ++ 8 + 一 + 第7天 余10天 — 「1_2 — 66 〇7 — 窠14天 — — Z / 18 — [表2] 金黃葡萄 球菌 對照 谷月 (0. * 5%) 賴胺酸鹽酸鹽 (0.5%) 第0天 第3天 +++ -L +++ 一 — , L D +++ +++ +-H- 第5天 +++ 6 + 5 24 1 第7天 107 3 第10天 Γ 9 米1今穴 ------ 一 表1及表2分別係將利用接種有大腸桿菌及金黃葡萄球菌 之樣本之塗抹法之生菌數之測量結果彙總表。如表i所 示,接種有大腸桿菌之對照樣本十,確認樣本25t下保存 第3天及第5天檢測出生菌,但第7天後生菌全然未檢測 出。任一胺基酸之情形中,添加有^胺基酸之樣本中亦檢 測出比對照樣本多之生菌,但添加〇_胺基酸之樣本確認僅 檢測出比對照樣本少之生菌之傾向。如表2所示,接種有 金黃葡萄⑨®之樣本在添加L_胺基酸之樣纟中亦檢測出比 對照樣本多之生菌,但添加有D_胺基酸之樣本中僅檢測出 比L-胺基酸少之菌數。另,該等樣本調製時之均在 至6.1之範圍内,可知不會對大腸桿菌及金黃葡萄球菌之 增殖帶來太大影響。又,相同胺基酸之1_體與D_體中口^相 同。因此,認為所添加之胺基酸之光學異性之差異係對生 156307.doc 201201857 菌數帶來較大差異之原因。即,L_胺基酸使2_苯氧乙醇之 防腐力降低,但D-胺基酸抑制2_笨氧乙醇之防腐力降低。 D-谷胺酸及D-賴胺酸鹽酸鹽抑制2_苯氧乙醇之防腐力降低 之效果顯著。 實施例2 以下係基於本發明,顯示含D_谷胺酸及/或〇_賴胺酸鹽 酸顏之飲料、乳霜、身體用乳霜、凝膠劑、剝離式面膜、 浸透式面膜、乳液、化妝水及氣溶膠劑之調配例。該等調 配例係以例示為目的而列舉者,不意圖限定本發明之技術 範圍。 調配例1(飲料) 調配量(g/60 mL中) 1.6 1.6 (組合物) 金銀花提取物 人參提取物 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 1>6 還原麥芽糖糖漿 28 赤蘚糖醇 8 檸檬酸 2 香料 1.3 N-乙醯葡萄糖胺 1 透明質酸鈉 0.5 維他命E 0.3 維他命B6 〇.2 156307.doc 201201857 維他命B 2 0.1 α-硫辛酸 0.2 輔酶Q10 1.2 神經醯胺(魔芋提取物) 0.4 L-脯胺酸 2 純水 剩餘 60 調配量(質量%) 3 1The antiseptic effect test was carried out as follows: L_body 0.5% (mass ratio, glutamic acid or lysine hydrochloride D· the same below), 5% nitroglycerin (Dynamite glycerol), 〇.5% of 2 • Phenoxyethanol is dissolved in the remaining deionized water to prepare a sample. A sample without added amino acid was used as a control. A 30 g sample was inoculated with 106 cfu/g of Escherichia coli or Staphylococcus aureus and stored at 25 °C. When the sample was prepared (0 days) and stored for 3, 5, 1 and 14 days, a part of the sample was taken with a sterile cotton swab, spread on an agar medium, and cultured at 30 ° C for 2 days, and the measurement was formed. The number of colonies. When the number of colonies exceeds about 100, the number of colonies is recorded as +++, and +. Recorded as - when the colony was not formed at all. The results of the antiseptic effect test are shown in Tables 2 and 2 below. 156307.doc -6 · 201201857 [Table 1] Escherichia coli control trough β (0. Τ 5%) lysine hydrochloride (0.5%) Day 0 +-H- ++Η- D +Ή-- L +-H- D HH- Brother 3 days 5th day 24 6 ··~~~-~~-- ++ 8 + one + 10 days in the 7th day - "1_2 — 66 〇 7 — 窠 14 days — Z / 18 — [Table 2] Staphylococcus aureus control Gu Yue (0. * 5%) lysine hydrochloride (0.5%) Day 0 Day 3 +++ -L +++ I -- , LD + ++ +++ +-H- Day 5 +++ 6 + 5 24 1 Day 7 107 3 Day 10 Γ 9 m 1 Today ------ One Table 1 and Table 2 will be utilized separately A summary of the results of the measurement of the number of bacteria inoculated with a sample of Escherichia coli and Staphylococcus aureus. As shown in Table i, a control sample of Escherichia coli was inoculated, and the sample was confirmed to be stored on the 3rd and 5th day at 25t. The bacteria were detected, but the bacteria were not detected at the 7th day. In the case of any amino acid, more bacteria than the control sample were detected in the sample with the amino acid added, but the 〇-amino group was added. The acid sample confirmed that only the tendency of the bacteria to be less than the control sample was detected. As shown in Table 2, inoculation The sample of Golden Grape 9® also detected more bacteria than the control sample in the sample containing L_amino acid, but only the sample added with D_amino acid detected less than L-amino acid. The number of bacteria is also in the range of 6.1, which does not affect the proliferation of Escherichia coli and Staphylococcus aureus. Also, the 1_body and D_ of the same amino acid The difference in optical heterogeneity of the added amino acid is considered to be the reason for the large difference in the number of bacteria of 156307.doc 201201857. That is, L_amino acid makes 2-phenoxyethanol The anti-corrosion power is lowered, but the D-amino acid inhibits the reduction of the anti-corrosion power of the 2-phenyl alcohol. D-glutamic acid and D-lysine hydrochloride have a remarkable effect of inhibiting the reduction of the anti-corrosion of 2-phenoxyethanol. Example 2 The following is based on the present invention and shows a beverage containing D_glutamic acid and/or guanidine-lysine acid, a cream, a body cream, a gel, a peeling mask, a soaking mask, Examples of the preparation of emulsions, lotions, and aerosols. These formulations are listed for the purpose of illustration and are not intended to limit the present invention. Technical range. Formulation Example 1 (beverage) Formulation amount (g/60 mL) 1.6 1.6 (Composition) Honeysuckle extract Ginseng extract D-glutamic acid and/or D-lysine hydrochloride 1> 6 Reducing Maltose Syrup 28 Erythritol 8 Citric Acid 2 Perfume 1.3 N-Acetyl Glucosamine 1 Sodium Hyaluronate 0.5 Vitamin E 0.3 Vitamin B6 〇.2 156307.doc 201201857 Vitamin B 2 0.1 α-Lipoic Acid 0.2 Coenzyme Q10 1.2 Neural guanamine (konjac extract) 0.4 L-proline 2 pure water remaining 60 ration (% by mass) 3 1

8 5 2 3 6 2 0.5 4 0.5 m 3 調配例2(乳霜) 液體石蠟 凡士林 二曱基聚矽氧烷 硬脂醇 山窬醇 甘油 二丙二醇 澳洲堅果油 硬化油 角鯊烷 硬脂酸 羥基硬脂酸膽固醇酯 2 -乙基己酸十六烧酉旨 聚氧乙烯硬化蓖麻油 自乳化型單硬脂酸甘油 156307.doc 201201857 氫氧化鉀 0.15 六偏磷酸鈉 0.05 三甲基甘胺酸 2 α-生育酚2-L-抗壞血酸 磷酸二酯鉀 1 醋酸生育酚 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 對羥基苯甲酸酯 適量 乙二胺四乙酸三鈉 0.05 4-t-丁基-4’-曱氧基二苯甲醯曱烷 0.05 二對曱氧基肉桂酸單-2- 乙基己酸甘油酯 0.05 著色劑 適量 叛乙稀聚合物 0.05 純水 剩餘 100.00 調配例3(身體用乳液) 調配量(質量%) 3 13 12 (組合物) 二甲基聚矽氧烷 十甲基環五矽氧烷 十二曱基環六矽氧烷 聚氧乙烯·甲基聚矽氧烷共聚物 156307.doc -10· 201201857 乙醇 2 異丙醇 1 甘油 3 二丙二醇 5 聚乙二醇6000 5 六偏磷酸鈉 0.05 醋酸生育酚 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 茴香提取物 0.1 金縷梅提取物 0.1 人參提取物 0.1 L-薄荷醇 適量 對羥基苯甲酸酯 適量 乙二胺四乙酸三鈉 0.05 二嗎淋基璉°秦酮 0.01 三甲氧基肉桂酸甲基雙(三曱基矽氧基) 矽烷基異戊酯 0.1 黃色氧化鐵 ‘適量 鈦酸錄 適量 二曱基二硬脂基銨水輝石 1.5 聚乙烯醇 0.1 羥乙基纖維素 0.1 三曱基矽烷氧基矽酸 2 156307.doc -π - 201201857 香料 純水 適量 剩餘 100.00 調配例4(凝膠劑) (組合物) 二甲基聚矽氧烷 甘油 1,3-丁二醇 聚乙二醇1500 聚乙二醇20000 辛酸十六烷酯 檸檬酸 檸檬酸鈉 六偏磷酸鈉 甘草酸二钟 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 醋酸生育酚 黃芩提取物 虎耳草提取物 乙二胺四乙酸三鈉 黃原膠 丙烯酸·甲基丙烯酸 調配量(質量°/〇) 5 2 5 3 3 3 0.01 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 156307.doc -12- 201201857 烧醋共聚物(Pemulen TR-2) 0.05 瓊脂粉 1.5 2-苯氧乙醇 適量 二丁基羥基曱苯 適量 純水 剩餘 100.00 調配例5(剝離式面膜) (組合物) 調配量(質量%) 乙醇 10 1,3-丁二醇 聚乙二醇 橄欖油 澳洲堅果油 羥基硬脂酸植物甾醇 乳酸 乳酸納 L-抗壞血酸硫酸酯2鈉 α-生育酚2-L-抗壞血 酸麟酸二S旨奸 6 2 0.05 0.058 5 2 3 6 2 0.5 4 0.5 m 3 Formulation Example 2 (cream) Liquid paraffin Vaseline dimercapto polyoxyalkylene stearyl behenyl glycerol dipropylene glycol macadamia nut oil hardening oil squalane stearic acid hydroxy hard Cholesteric acid cholesterol ester 2-ethylhexanoic acid hexahydrate 酉 聚 polyoxyethylene hardened castor oil self-emulsifying monostearic acid glycerol 156307.doc 201201857 potassium hydroxide 0.15 sodium hexametaphosphate 0.05 trimethylglycine 2 α - Tocopherol 2-L-ascorbyl phosphate diester potassium 1 Tocopherol acetate 0.1 D-glutamic acid and / or D-lysamine hydrochloride 0.5 Parabens amount Ethylenediaminetetraacetic acid trisodium 0.05 4 -t-butyl-4'-decyloxybenzophenone 0.05 di-p-oxy cinnamic acid mono-2-ethylhexanoic acid glyceride 0.05 coloring agent appropriate amount of tethered polymer 0.05 pure water remaining 100.00 Formulation Example 3 (Body Emulsion) Formulation amount (% by mass) 3 13 12 (Composition) Dimethyl polyoxane decamethylcyclopentaoxane, 12-fluorenylcyclohexaoxane, polyoxyethylene, A Polyoxyalkylene copolymer 156307.doc -10· 201201857 Ethanol 2 Isopropanol 1 Glycerin 3 Dipropylene glycol 5 Polyethylene glycol 6000 5 Sodium metaphosphate 0.05 Tocopherol acetate 0.1 D-glutamic acid and/or D-lysine hydrochloride 0.1 Fennel extract 0.1 Witch hazel extract 0.1 Ginseng extract 0.1 L-menthol Phenyl paraben Appropriate amount of trisodium edetate 0.05 吗 淋 琏 琏 秦 酮 0.01 0.01 0.01 0.01 Trimethoxy cinnamic acid methyl bis (tridecyl decyloxy) decyl isoamyl ester 0.1 yellow iron oxide 'the right amount of titan acid recorded two Mercapto distearyl ammonium hectorite 1.5 polyvinyl alcohol 0.1 hydroxyethyl cellulose 0.1 tridecyl decyloxy decanoic acid 2 156307.doc -π - 201201857 Perfume pure water amount remaining 100.00 Preparation example 4 (gelling agent) (composition) dimethyl polyoxyalkylene glycerol 1,3-butanediol polyethylene glycol 1500 polyethylene glycol 20000 cetyl octyl citrate citrate sodium hexametaphosphate glycyrrhizic acid two D-valley Amino acid and / or D-lysamine hydrochloride tocopherol extract Astragalus extract Saxifrag extract Ethylenediaminetetraacetic acid trisodium xanthan gum Acrylic acid / Methacrylic acid blending amount (mass ° / 〇) 5 2 5 3 3 3 0.01 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 156307.doc -12- 201201857 Polymer (Pemulen TR-2) 0.05 Agar powder 1.5 2-Phenoxyethanol Appropriate amount of dibutylhydroxyindole Benzene Appropriate amount of pure water remaining 100.00 Formulation Example 5 (peeling mask) (composition) Formulation amount (% by mass) Ethanol 10 1 ,3-butanediol polyethylene glycol olive oil macadamia nut oil hydroxystearic acid plant sterol lactate lactate L-ascorbyl sulfate 2 sodium alpha-tocopherol 2-L-ascorbate two S-sex 6 6 0.05

D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 魚膠原 0.1 硫酸軟骨素鈉 0.1 156307.doc -13- 201201857 羥甲纖維素鈉 0.2 聚乙烯醇 12 對羥基苯甲酸酯 適量 香料 適量 純水 剩餘 100.00 調配例6(浸透式面膜) (組合物) 調配量(質量%) 甘油 1 1,3-丁二醇 8 木糖醇 2 聚乙二醇1500 2 迷迭香油 0.01 鼠尾草油 0.1 檸檬酸 0.02 檸檬酸鈉 0.08 六偏磷酸鈉 0.01 羥丙基-β-環糊精 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 白樺提取物 0.1 薰衣草油 0.01 黃原膠 0.05 156307.doc -14· 201201857 羧基乙烯聚合物 對羥基苯甲酸酯 純水 調配例7(乳液) (組合物) 液體石蠟 凡士林 十五甲基環五矽氧烷 山茶醇 甘油 二丙二醇 聚乙二醇1500 荷荷巴油 異硬脂酸 硬脂酸 山蓊酸 四(2-乙基己酸)季戊四醇酯 2 -乙基己酸十六烧酉旨 單硬脂酸甘油酯 單硬脂酸聚氧乙烯甘油酯 氫氧化鉀 六偏填酸納 0.15 適量 剩餘 100.00 調配量(質量%) 7 3 2 1.5 5 7 2 1 0.5 0.5 0.5 3 3 0.05 156307.doc 15 201201857 甘草次酸硬脂酯 0.05 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 1 蜂王漿提取物 0.1 酵母提取物 0.1 醋酸生育酚 0.1 乙醯化透明質酸鈉 0.1 乙二胺四乙酸三鈉 0.05 4-t-丁基-4'-曱氧基二苯甲醯基曱烷0.1 對甲氧基桂皮酸2-乙基己酯 0.1 羧基乙烯聚合物 0.15 對羥苯甲酸酯 適量 香料 適量 純水 剩餘 100.00 調配例8(乳液) (組合物) 調配量(質量%) 二甲基聚矽氧烷 2 山蓊醇 1 鯊肝醇 0.5 甘油 5 1,3-丁二醇 7 赤蘚糖醇 2 156307.doc -16- 201201857 硬化油 3 角鯊烯 6 四(2-乙基己酸)季戊四醇酯 2 異硬脂酸聚氧乙烯甘油 1 單硬脂酸聚氧乙烯甘油 1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.3 氫氧化鉀 適量 六偏磷酸鈉 0.05 2-苯氧乙醇 適量 羧基乙烯聚合物 0.1 純水 剩餘 調配例9(化妝水) (組合物) 乙醇 甘油 100.00 調配量(質量%) 5 1,3-丁二醇 5 聚環氧乙烷聚環氧丙烷 癸基十四烷基醚 0.2 六偏磷酸鈉 0.03 三甲基甘胺酸 1 聚天冬醯胺酸鈉 0.1 156307.doc •17- 201201857 α-生育酚2-抗壞血酸 磷酸二酯鉀 0.1 硫代牛磺酸 0.1 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.01 EDTA3鈉 0.1 羧基乙烯基聚合物 0.05 氫氧化鉀 0.02 2-苯氧乙醇 適量 香料 適量 純水 剩餘 anoea·——a—ani, a ιι 丨_ ga—aesanaiaca—casaaagaca—aegxaasaMnae—iea!ani,.mn_i8»acceaiEsa 100.00 調配例10(化妝水) (組合物) 調配(I 乙醇 10 二丙二醇 1 聚乙二醇1000 1 聚氧乙烯甲基葡糖苷 1 荷荷巴油 0.01 三2-乙基己酸甘油酯 0.1 聚氧乙烯硬化蓖麻油 0.2 二異硬脂酸聚甘油酯 0.15 N-硬脂醯基-L-谷胺酸鈉 0.1 •18- 156307.doc 201201857 檸檬酸 0.05 擰檬酸鈉 0.2 氫氧化鉀 0.4 甘草酸二鉀 0.1 精胺酸鹽酸鹽 0.1 L-抗壞血酸2-葡糖苷 2 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.5 乙二胺四乙酸三鈉 0.05 對曱氧基桂皮酸2-乙基己酯 0.01 二丁基羥基曱苯 適量 對羥基苯曱酸酯 適量 海洋深層水 3 香料 適量 純水 剩餘 100.00 調配例11(氣溶膠尿素外用劑原液) (組合物) 調配量 乙醇 15.0 聚氧乙烯硬化蓖麻油50 1.5 二苯海拉明 1.0 辛可卡因(dibucaine) 2.0 醋酸生育酚 0.5 -19- 156307.doc 201201857 D-谷胺酸 及/或D-賴胺酸鹽酸鹽 0.1 異硬脂酸 0.1 1,3-丁二醇 3.0 聚乙二醇4〇〇 3.0 樟腦 0.05 尿素 20.0 純水 剩餘 100.00 調配例12(氣溶膠尿素喷射劑) (組合物) 調配量(質量〇/〇) 氣溶膠展素外用劑原液 65.0 35.0 二甲醚 100.00 調配例12(氣溶膠尿素喷射劑)之填充方法 將氣溶膠尿料用劑原液及2甲趟填充於内©經鐵氟隆 (註冊商標)塗佈處理之耐壓氣溶膠鋁罐内,調製氣溶膠 劑。 156307.docD-glutamic acid and/or D-lysamine hydrochloride 0.1 Fish collagen 0.1 Chondroitin sulfate 0.1 156307.doc -13- 201201857 Sodium hydroxymethylcellulose 0.2 Polyvinyl alcohol 12 Parabens Appropriate amount of pure water remaining 100.00 Formulation Example 6 (Immersion Mask) (Composition) Formulation amount (% by mass) Glycerin 1 1,3-butanediol 8 Xylitol 2 Polyethylene glycol 1500 2 Rosemary oil 0.01 Sage Oil 0.1 Citric acid 0.02 Sodium citrate 0.08 Sodium hexametaphosphate 0.01 Hydroxypropyl-β-cyclodextrin 0.1 D-glutamic acid and / or D-lysamine hydrochloride 0.5 White birch extract 0.1 Lavender oil 0.01 Huangyuan Gum 0.05 156307.doc -14· 201201857 Carboxyvinyl polymer p-hydroxybenzoate pure water formulation Example 7 (emulsion) (composition) Liquid paraffin Vaseline pentamethylcyclopentaoxane Camelliere glycerol dipropylene glycol polyethylene Glycol 1500 jojoba oil isostearic acid stearic acid behenic acid tetrakis(2-ethylhexanoic acid) pentaerythritol ester 2-ethylhexanoic acid hexahydrate glycerol monostearate monostearate Oxyethylene glyceride potassium hydroxide hexaploxate 0.15 appropriate amount of remaining 100.00 Mass%) 7 3 2 1.5 5 7 2 1 0.5 0.5 0.5 3 3 0.05 156307.doc 15 201201857 Glycyrrhetinic acid stearyl ester 0.05 D-glutamic acid and / or D-lysamine hydrochloride 1 Royal jelly extract 0.1 Yeast Extract 0.1 Tocopherol Acetate 0.1 Acetate Sodium Hyaluronate 0.1 Ethylenediaminetetraacetic Acid Trisodium 0.05 4-t-Butyl-4'-decyloxybenzhydryldecane 0.1 P-Methoxy Cinnamon Acid 2-ethylhexyl ester 0.1 Carboxyvinyl polymer 0.15 Parabens Appropriate amount of spices Right amount of pure water remaining 100.00 Formulation Example 8 (emulsion) (composition) Formulation amount (% by mass) Dimethylpolysiloxane 2 Kaempferol 1 Shark liver alcohol 0.5 Glycerol 5 1,3-butanediol 7 Erythritol 2 156307.doc -16- 201201857 Hardened oil 3 Squalene 6 Tetrakis(2-ethylhexanoate) pentaerythritol 2 Stearic acid polyoxyethylene glycerol 1 monostearate polyoxyethylene glycerol 1 D-glutamic acid and / or D-lysamine hydrochloride 0.3 potassium hydroxide amount of sodium hexametaphosphate 0.05 2-phenoxyethanol appropriate amount of carboxyl Ethylene polymer 0.1 pure water remaining formulation example 9 (makeup) (composition) ethanol glycerin 100.00 dosage (% by mass) 5 1,3-butanediol 5 polyethylene oxide polypropylene oxide decyltetradecyl ether 0.2 sodium hexametaphosphate 0.03 trimethylglycine 1 polyaspartic sodium citrate 0.1 156307.doc • 17- 201201857 α-Tocopherol 2-Ascorbyl Phosphate Diester Potassium 0.1 Thio Taurine 0.1 D-Glutamic Acid and/or D-Lysamine Hydrochloride 0.01 EDTA3 Sodium 0.1 Carboxyvinyl Polymer 0.05 Potassium Hydroxide 0.02 2-phenoxyethanol, the right amount of spices, the amount of pure water remaining anoea·——a—ani, a ιι 丨_ ga—aesanaiaca—casaaagaca—aegxaasaMnae—iea!ani,.mn_i8»acceaiEsa 100.00 Formulation Example 10 (lotion) (Combination Formulation (I ethanol 10 dipropylene glycol 1 polyethylene glycol 1000 1 polyoxyethylene methyl glucoside 1 jojoba oil 0.01 triethyl 2-ethylhexanoate 0.1 polyoxyethylene hardened castor oil 0.2 diisostearyl Acid polyglyceride 0.15 N-stearyl sulfhydryl-L-glutamate 0.1 • 18- 156307.doc 201201857 Citric acid 0.05 sodium citrate 0.2 potassium hydroxide 0.4 dipotassium glycyrrhizinate 0.1 arginine hydrochloride 0.1 L-ascorbic acid 2-glucoside 2 D-glutamic acid and / or D-lysamine hydrochloride 0.5 Ethylenediaminetetraacetic acid trisodium 0.05 p-Oxyl cinnamic acid 2-ethylhexyl ester 0.01 Dibutyl hydroxy fluorene benzophenone p-hydroxyphenyl phthalate Appropriate amount of marine deep water 3 Perfume amount of pure water remaining 100.00 Preparation example 11 ( Aerosol urea external preparation) (composition) Formulation ethanol 15.0 Polyoxyethylene hardened castor oil 50 1.5 Diphenhydramine 1.0 dicocaine 2.0 Tocopherol acetate 0.5 -19- 156307.doc 201201857 D-glutamine Acid and / or D-lysamine hydrochloride 0.1 isostearic acid 0.1 1,3-butanediol 3.0 polyethylene glycol 4 〇〇 3.0 camphor 0.05 urea 20.0 pure water remaining 100.00 Preparation example 12 (aerosol urea injection Agent) (composition) Formulation amount (mass 〇 / 〇) Aerosol exhibitant external preparation stock solution 65.0 35.0 Dimethyl ether 100.00 Preparation method 12 (aerosol urea spray agent) filling method Aerosol urine material preparation liquid and 2 The formazan is filled in a pressure-resistant aerosol aluminum can coated with Teflon (registered trademark) to prepare an aerosol. 156307.doc

Claims (1)

201201857 七、申請專利範圍·· u 一種含胺基酸組合物中之防腐力降低抑制劑,其特徵在 於其含有D-胺基酸。 2. 如睛求項1之含胺基酸組合物中之防腐力降低抑制劑, 其中則述D-胺基酸係D-谷胺酸及/或D_賴胺酸鹽酸鹽。 3. 如請求項1或2之含胺基酸組合物中之防腐力降低抑制 劑,其調配量為0.000015質量%至1〇質量%,並與〇 〇1質 量%至1.0質量%之防腐劑併用。 4. 一種化妝品,其特徵在於:其含有如請求項1至3中任一 項之含胺基酸組合物中之防腐力降低抑制劑。 156307.doc 201201857 四、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: (無) 156307.doc201201857 VII. Patent Application Range·· u An anti-corrosion reduction inhibitor in an amino acid-containing composition, which is characterized in that it contains a D-amino acid. 2. The antiseptic reduction inhibitor according to the amino acid-containing composition of claim 1, wherein the D-amino acid is D-glutamic acid and/or D_lysine hydrochloride. 3. The anti-corrosion reducing inhibitor in the amino acid-containing composition of claim 1 or 2, which is formulated in an amount of from 0.00015% by mass to 1% by mass, and with from 1% by mass to 1.0% by mass of the preservative And use it. A cosmetic comprising the anti-corrosion reducing inhibitor in the amino acid-containing composition according to any one of claims 1 to 3. 156307.doc 201201857 IV. Designation of the representative representative: (1) The representative representative of the case is: (none) (2) The symbol of the symbol of the representative figure is simple: 5. If there is a chemical formula in this case, please reveal the best indication of the characteristics of the invention. Chemical formula: (none) 156307.doc
TW100119456A 2010-06-09 2011-06-02 Agent suppressing decrease in preservative ability in amino-acid containing composition TW201201857A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010132388A JP2011256137A (en) 2010-06-09 2010-06-09 Agent suppressing decrease in preservative ability in amino acid-containing composition
PCT/JP2011/060904 WO2011155280A1 (en) 2010-06-09 2011-05-12 Agent suppressing decrease in preservative ability in amino-acid containing composition

Publications (1)

Publication Number Publication Date
TW201201857A true TW201201857A (en) 2012-01-16

Family

ID=45097892

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100119456A TW201201857A (en) 2010-06-09 2011-06-02 Agent suppressing decrease in preservative ability in amino-acid containing composition

Country Status (3)

Country Link
JP (1) JP2011256137A (en)
TW (1) TW201201857A (en)
WO (1) WO2011155280A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3047495A1 (en) 2016-12-21 2018-06-28 Unilever Plc Topical skin lightening additive and composition with amino acids and nicotinamide compounds
US11337908B2 (en) 2016-12-21 2022-05-24 Conopco, Inc. Personal care compositions with cystine
WO2018114745A1 (en) 2016-12-21 2018-06-28 Unilever Plc Personal care compositions comprising poorly soluble compounds
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
EP3822288A1 (en) * 2019-11-18 2021-05-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Antibodies targeting, and other modulators of, the cd276 antigen, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57158724A (en) * 1981-03-26 1982-09-30 Shiseido Co Ltd Antimicrobial composition
JPH05229924A (en) * 1992-02-25 1993-09-07 Nippon Zetotsuku Kk Composition for oral cavity
JP2521632B2 (en) * 1993-04-19 1996-08-07 花王株式会社 Hair deformer composition
AU4068400A (en) * 1999-05-06 2000-11-21 Biospherics Incorporated Method for preventing or minimizing biodegradation of a substance

Also Published As

Publication number Publication date
JP2011256137A (en) 2011-12-22
WO2011155280A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
JP6653342B2 (en) Topical oil compositions for the treatment of fungal infections
EP2405885B1 (en) Thickening additive compositions for sunscreen formulations
JP5637987B2 (en) Preservative composition
CN1242701A (en) Compositions contg. antifungal and cationic agent
JP5507146B2 (en) Water-in-oil emulsified paste pharmaceutical preparation for lips
SA109300373B1 (en) Compositions for Lightening Skin Color
TW201201857A (en) Agent suppressing decrease in preservative ability in amino-acid containing composition
JP5302239B2 (en) Antiseptic disinfectant and human body composition
JP2018127445A (en) Composition for external use
JP5550863B2 (en) Cosmetics
CZ295985B6 (en) Body and hair cleansing composition containing fungicidal agent and phospholipid as well as process for preparing such composition
JP2019210250A (en) Preservative composition containing isopentyldiol
JP2007169192A (en) Hair cosmetics
JP6971518B2 (en) Antibacterial composition containing thymol, terpineol, and cationic phospholipids
KR20160044071A (en) Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient
JP5013753B2 (en) Antiseptic disinfectant composition
KR101585795B1 (en) Preservative composition containing diethylene glycol monobenzyl ether as an active ingredient
JP5264829B2 (en) Antiseptic disinfectant and cosmetic composition
JP2018052887A (en) Aqueous preparation
JP6900121B2 (en) Antiperspirant composition and antiperspirant
JP2018052886A (en) Aqueous formulation
JP2009167139A (en) External use composition
JP4294640B2 (en) Antiseptic disinfectant, cosmetics or pharmaceuticals containing the antiseptic disinfectant, and antiseptic disinfection method
CN109939090A (en) novel use
TW201345558A (en) External preparation for skin